MedPath

Jinarc

Brand Name: Jinarc

Generic Name: Tolvaptan

Active
Registration Number

DR-XY48517

Dosage Form

Tablet

Issuance Date

December 1, 2022

Expiry Date

December 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength15mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (Rx)
A
Application
Monitored Release
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

TolvaptanActive
Monograph: Tolvaptan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform